BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2125417)

  • 1. [Mortality in cardiac insufficiency. Evaluation of prognosis, influence of treatments].
    Komajda M; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1975-80. PubMed ID: 2125417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of heart failure].
    Follath F
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug treatment of left ventricular insufficiency. Current aspects].
    Jaeger P; Cohen Solal A; Dahan M; Juliard JM; Charlier P; Gourgon R
    Rev Mal Respir; 1987; 4(6):287-94. PubMed ID: 3327120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How are tachycardic cardiac arrhythmias modified by therapy of congestive heart failure?].
    Meinertz T; Hofmann T; Drexler H; Zehender M; Just H
    Herz; 1990 Jun; 15(3):207-13. PubMed ID: 2198221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
    Thormann J; Kramer W; Dieterich HA
    Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatment of heart insufficiency].
    Follath F
    Schweiz Med Wochenschr; 1988 Dec; 118(50):1886-91. PubMed ID: 3065935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positive inotropic substances--therapeutic perspectives].
    Erdmann E; Böhm M
    Z Kardiol; 1991; 80 Suppl 8():57-62. PubMed ID: 1796636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of cardiac insufficiency. Advances and controversies].
    Garnier LF
    Arch Mal Coeur Vaiss; 1988 Apr; 81(4):551-6. PubMed ID: 3136718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can pharmacological therapy influence the mortality of chronic congestive heart failure?
    Widimský J
    Cor Vasa; 1992; 34(1):15-30. PubMed ID: 1288941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.